Provided By GlobeNewswire
Last update: May 14, 2025
SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company pioneering the development of systemic oncolytic targeted immunotherapies with the potential to deliver genetic payloads, today reported its first quarter 2025 operating and financial results and reviewed recent business highlights.
Read more at globenewswire.comNYSEARCA:CLDI (7/14/2025, 9:33:10 AM)
0.66
-0.1 (-13.16%)
Find more stocks in the Stock Screener
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.
After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Wondering how the US markets performed one hour before the close of the markets on Thursday? Discover the movers and shakers of today's session in our comprehensive analysis.
Let's dive into the action on the US markets on Thursday. Here are the most active stocks that are driving the market today.
Let's have a look at the stocks with an unusual volume in today's session.
Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes.
Get a pulse on the US markets on Wednesday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity.
Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top gainers and losers in today's pre-market session.
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.